Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplemental Table S3 from Tusamitamab Ravtansine in Patients with Advanced Solid Tumors: Phase I Study of Safety, Pharmacokinetics, and Antitumor Activity Using Alternative Dosing Regimens
  1. Home
  2. Publications
  3. Supplemental Table S3 from Tusamitamab Ravtansine in Patients with Advanced Solid Tumors: Phase I Study of Safety, Pharmacokinetics, and Antitumor Activity Using Alternative Dosing Regimens

Supplemental Table S3 from Tusamitamab Ravtansine in Patients with Advanced Solid Tumors: Phase I Study of Safety, Pharmacokinetics, and Antitumor Activity Using Alternative Dosing Regimens

Authors:
  • JTJosep Tabernero
    Josep Tabernero
  • PBPhilippe L. Bedard
    Philippe L. Bedard
  • Yung-Jue Bang
    Yung-Jue Bang
  • MVMaria Vieito
    Maria Vieito
  • MRMin-Hee Ryu
    Min-Hee Ryu
  • NFNathalie Fagniez
    Nathalie Fagniez
  • MCMustapha Chadjaa
    Mustapha Chadjaa
  • CSChristine Soufflet
    Christine Soufflet
  • NMNina Masson
    Nina Masson
  • AGAnas Gazzah
    Anas Gazzah

Open Access
Publisher website
Google Scholar
  • 28 August 2023
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2767-9764.24043011
Abstract
No abstract available
Keywords
  • LUNG CANCER
  • GASTROINTESTINAL CANCERS
  • BIOMARKERS
  • CLINICAL TRIAL RESULTS
  • PHASE I CLINICAL TRIALS
  • BIOLOGICAL AGENTS & THERAPIES
  • ANTIBODY-DRUG CONJUGATES
  • DRUG TARGETS
  • CELL SURFACE RECEPTOR DRUG TARGETS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.